Zanubrutinib versus ibrutinib in Waldenström macroglobulinaemia Presented ByProf. Meletios Dimopoulos, University of Athens, Greece TrialPhase 3, ASPEN ConferenceEHA 2020 TypePeer-reviewed article 9 September 2020 12:10